Viral Hepatitis

You have full text access to this OnlineOpen article

Extrahepatic manifestations of hepatitis C among United States male veterans

  1. Hashem B. El-Serag M.D., Mph1,3,*,
  2. Howard Hampel2,3,
  3. Christine Yeh3,
  4. Linda Rabeneck1,3

Article first published online: 7 MAR 2007

DOI: 10.1002/hep.1840360621

Issue

Hepatology

Hepatology

Volume 36, Issue 6, pages 1439–1445, December 2002

Additional Information

How to Cite

El-Serag, H. B., Hampel, H., Yeh, C. and Rabeneck, L. (2002), Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology, 36: 1439–1445. doi: 10.1002/hep.1840360621

Author Information

  1. 1

    Section of Gastroenterology The Houston Veterans Affairs Medical Center, Houston, TX

  2. 2

    Section of Health Services Research at The Houston Veterans Affairs Medical Center, Houston, TX

  3. 3

    Department of Medicine at Baylor College of Medicine, Houston, TX

*The Houston Veterans Affairs Medical Center (152), 2002 Holcombe Blvd., Houston, TX 77030. fax: 713–748–7359

Publication History

  1. Issue published online: 7 MAR 2007
  2. Article first published online: 7 MAR 2007
  3. Manuscript Accepted: 22 SEP 2002
  4. Manuscript Received: 21 JUN 2002

Funded by

  • National Institutes of Health Career Award. Grant Number: K24 DK59318

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (768K)

Reference

  • 1
    Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 446–562.
  • 2
    Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615–620.
  • 3
    Boyko EJ, Koepsell TD, Gaziano JM, Horner RD, Feussner JR. US Department of Veterans Affairs medical care system as a resource to epidemiologists. Am J Epidemiol 2000; 151: 307–314.
  • 4
    Cosio FG, Roche Z, Agarwal A, Falkenhain ME, Sedmak DD, Ferguson RM. Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J Kidney Dis 1996; 28: 752–758.
  • 5
    Lopes LM, Lopes EP, Silva E, Kirsztajn GM, Pereira AB, Sesso RC, Ferraz ML. Prevalence of hepatitis C virus antibodies in primary glomerulonephritis in Brazil. Am J Nephrol 1998; 18: 495–497.
  • 6
    Gopalani A, Ahuja TS. Prevalence of glomerulopathies in autopsies of patients infected with the hepatitis C virus. Am J Med Sci 2001; 322: 57–60.
  • 7
    Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465–470.
  • 8
    Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328–333.
    Direct Link:
  • 9
    Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J, O'Rahilly S, et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 1059–1063.
    Direct Link:
  • 10
    Ozyilkan E, Arslan M. Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1996; 91: 1480–1481.
  • 11
    Ryu JK, Lee SB, Hong SJ, Lee S. Association of chronic hepatitis C virus infection and diabetes mellitus in Korean patients. Korean J Intern Med 2001; 16: 18–23.
  • 12
    Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 2000; 75: 355–359.
  • 13
    Mangia A, Schiavone G, Lezzi G, Marmo R, Bruno F, Villani MR, Cascavilla I, et al. HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol 1998; 93: 2363–2367.
    Direct Link:
  • 14
    Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592–599.
  • 15
    Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J, Teres J, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993; 341: 788–789.
  • 16
    Fargion S, Piperno A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, Caldarelli R, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992; 16: 1322–1326.
    Direct Link:
  • 17
    Kondo M, Horie Y, Okano J, Kitamura A, Maeda N, Kawasaki H, Mishiro S, et al. High prevalence of hepatitis C virus infection in Japanese patients with porphyria cutanea tarda. Hepatology 1997; 26: 246.
    Direct Link:
  • 18
    Murphy A, Dooley S, Hillary IB, Murphy GM. HCV infection in porphyria cutanea tarda. Lancet 1993; 341: 1534–1535.
  • 19
    Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, Tortorelli K, et al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 1998; 27: 1661–1669.
    Direct Link:
  • 20
    Lamoril J, Andant C, Bogard C, Puy H, Gouya L, Pawlotsky JM, Da Silva V, et al. Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda. Hepatology 1998; 27: 848–852.
    Direct Link:
  • 21
    DeCastro M, Sanchez J, Herrera JF, Chaves A, Duran R, Garcia-Buey L, Garcia-Monzon C, et al. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 1993; 17: 551–557.
    Direct Link:
  • 22
    Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, Yamamoto AM, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore), 2000; 79: 47–56.
  • 23
    Pawlotsky JM, Dhumeaux D, Bagot M. Hepatitis C virus in dermatology. Areview. Arch Dermatol 1995; 131: 1185–1193.
  • 24
    Grote M, Reichart PA, Berg T, Hopf U. Hepatitis C virus (HCV)-infection and oral lichen planus. J Hepatol 1998; 29: 1034–1035.
  • 25
    Dupin N, Chosidow O, Lunel F, Fretz C, Szpirglas H, Frances C. Oral lichen planus and hepatitis C virus infection: a fortuitous association? Arch Dermatol 1997; 133: 1052–1053.
  • 26
    Cribier B, Garnier C, Laustriat D, Heid E. Lichen planus and hepatitis C virus infection: an epidemiologic study. J Am Acad Dermatol 1994; 31: 1070–1072.
  • 27
    Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, Opolon P. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999; 42: 2204–2212.
    Direct Link:
  • 28
    Casato M, Taliani G, Pucillo LP, Goffredo F, Lagana B, Bonomo L. Cryoglobulinaemia and hepatitis C virus. Lancet 1991; 337: 1047–1048.
  • 29
    Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, Vendramin G, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573–577.
  • 30
    Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490–1495.
  • 31
    Cacoub P, Musset L, Lunel F, Fabiani PL, Perrin M, Leger JM, Thi Huong Du L, et al. Hepatitis C virus and essential mixed cryoglobulinaemia. Br J Rheumatol 1993; 32: 689–692.
  • 32
    Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, DeForges L, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841–848.
    Direct Link:
  • 33
    Kerr GS, Rofail M, Lewis JH, Kumar P, Seeff LB. Prevalence of hepatitis C virus associated cryoglobulinemia at a veterans hospital. J Rheumatol 1997; 24: 2134–2138.
  • 34
    Lee YH, Ji JD, Yeon JE, Byun KS, Lee CH, Song GG. Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection. Ann Rheum Dis 1998; 57: 728–731.
  • 35
    Kashyap A, Nademanee A, Molina A. Hepatitis C and B-cell lymphoma. Ann Intern Med 1998; 128: 695.
  • 36
    Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, Qian DG, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423–428.
  • 37
    Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, Lombardini F, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 392–394.
    Direct Link:
  • 38
    Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M, Sorio R, et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 544–550.
    Direct Link:
  • 39
    Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, Russo D, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296–4301.
  • 40
    Germanidis G, Haioun C, Dhumeaux D, Reyes F, Pawlotsky JM. Hepatitis C virus infection, mixed cryoglobulinemia, and B-cell non-Hodgkin's lymphoma. Hepatology 1999; 30: 822–823.
    Direct Link:
  • 41
    Brind AM, Watson JP, Burt A, Kestevan P, Wallis J, Proctor SJ, Bassendine MF. Non-Hodgkin's lymphoma and hepatitis C virus infection. Leuk Lymphoma 1996; 21: 127–130.
  • 42
    Collier JD, Zanke B, Moore M, Kessler G, Krajden M, Shepherd F, Heathcote J. No association between hepatitis C and B-cell lymphoma. Hepatology 1999; 29: 1259–1261.
    Direct Link:
  • 43
    Pioltelli P, Gargantini L, Cassi E, Santoleri L, Bellati G, Magliano EM, Morra E. Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case-control study of 300 patients. Lombart Study Group of HCV-Lymphoma. Am J Hematol 2000; 64: 95–100.
    Direct Link:
  • 44
    Hausfater P, Cacoub P, Rosenthal E, Bernard N, Loustaud-Ratti V, Le Lostec Z, Laurichesse H, et al. Hepatitis C virus infection and lymphoproliferative diseases in France: a national study. The GERMIVIC Group. Am J Hematol 2000; 64: 107–111.
    Direct Link:
  • 45
    Hausfater P, Cacoub P, Sterkers Y, Thibault V, Amoura Z, Nguyen L, Ghillani P, et al. Hepatitis C virus infection and lymphoproliferative diseases: Prospective study on 1,576 patients in France. Am J Hematol 2001; 67: 168–171.
    Direct Link:
  • 46
    Silvestri F, Barillari G, Fanin R, Pipan C, Falasca E, Salmaso F, Zaja F, et al. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica 1997; 82: 314–317.
  • 47
    Ferri C, Monti M, La Civita L, Careccia G, Mazzaro C, Longombardo G, Lombardini F, et al. Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinaemia. Eur J Clin Invest 1994; 24: 781–784.
    Direct Link:
  • 48
    Rasul I, Shepherd FA, Kamel-Reid S, Krajden M, Pantalony D, Heathcote EJ. Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology 1999; 29: 543–547.
    Direct Link:
  • 49
    Lloyd SS, Rissing JP. Physician and coding errors in patient records. JAMA 1985; 254: 1330–1336.
  • 50
    Kashner TM. Agreement between administrative files and written medical records. A case of the Department of Veterans Affairs. Med Care 1998; 36: 1324–1336.
Get PDF (768K)